Diabetes treatment is constantly advancing, with new therapeutic options developing to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the https://jasontsae824959.tokka-blog.com/39430192/novel-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment